Skip to main content
OpenTrials

Clinical trial condition

Tenosynovial Giant Cell Tumor

Explore clinical trials studying Tenosynovial Giant Cell Tumor. Study availability and eligibility vary by location and protocol.

16 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Tenosynovial Giant Cell Tumor trial results

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

NCT04192344

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +9 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
  • The Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 17 locations
View Trial Details
Recruiting

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

NCT04635111

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Hepatotoxicity, +10 more
Locations
  • Kamalesh K Sankhala MD INC Santa Monica, California, United States
  • Sarcoma Oncology Research Center LLC Santa Monica, California, United States
  • UCLA Hematology and Oncology Santa Monica, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
View Trial Details
Completed

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

NCT04703322

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +10 more
Locations
  • Nagoya University Hospital Aichi, Japan
  • Kyushu University Hospital Fukuoka, Japan
  • Kanazawa University Hospital Ishikawa, Japan
  • National Hospital Organization Osaka National Hospital Osaka, Japan
View Trial Details
Completed

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

NCT01207492

Conditions
Diffuse-type Giant Cell Tumor, Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, +12 more
Locations
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib

NCT04526704

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +9 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Completed

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

NCT05349643

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +12 more
Locations
  • AmMax Bio, Clinical Site Sacramento, California, United States
  • AmMax Bio, Clinical Site Miami, Florida, United States
  • AmMax Bio, Clinical Site Houston, Texas, United States
  • AmMax Bio, Clinical Site Camperdown, Australia
View Trial Details
Completed

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

NCT04731675

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
Locations
  • AmMax Bio Clinical Site Columbus, Ohio, United States
  • AmMax Bio Clinical Site Leiden, Netherlands
  • AmMax Bio Clinical Site Warsaw, Poland
  • AmMax Bio Clinical Site Dnipro, Ukraine
View Trial Details

Related conditions